We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Change in
Stake
CIC
101
Cornercap Investment Counsel
Georgia
$448K -$421K -28,229 -50%
TPSF
102
Texas Permanent School Fund
Texas
$435K -$10.1K -680 -2%
VAM
103
Verity Asset Management
North Carolina
$435K +$94.6K +6,339 +30%
VIA
104
Vident Investment Advisory
Georgia
$434K +$84.7K +5,680 +26%
Public Sector Pension Investment Board (PSP Investments)
105
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$426K
GAM
106
Gotham Asset Management
New York
$420K -$223K -14,941 -36%
Nisa Investment Advisors
107
Nisa Investment Advisors
Missouri
$374K +$134K +9,000 +62%
UBS AM
108
UBS AM
Illinois
$369K
MC
109
Menta Capital
California
$361K
MIM
110
MetLife Investment Management
New Jersey
$359K
LPL Financial
111
LPL Financial
California
$347K +$4.65K +312 +1%
Bank of America
112
Bank of America
North Carolina
$338K -$219K -14,712 -41%
LCM
113
Laurion Capital Management
New York
$329K +$309K +20,698 New
LSERS
114
Louisiana State Employees Retirement System
Louisiana
$302K +$2.98K +200 +1%
VOYA Investment Management
115
VOYA Investment Management
Georgia
$294K -$23.3K -1,561 -8%
FIM
116
Freedom Investment Management
Connecticut
$283K +$265K +17,794 New
AG
117
Advisor Group
Arizona
$273K +$106K +7,083 +70%
HIMCH
118
Hartford Investment Management Co (HIMCO)
Connecticut
$265K +$248K +16,639 New
PI
119
PineBridge Investments
New York
$258K -$12.2K -819 -5%
TRSOTSOK
120
Teachers Retirement System of the State of Kentucky
Kentucky
$258K
JMPWA
121
JP Morgan Private Wealth Advisors
California
$254K +$8.03K +538 +3%
Public Employees Retirement Association of Colorado
122
Public Employees Retirement Association of Colorado
Colorado
$244K
JIC
123
Johnson Investment Counsel
Ohio
$237K
MLICM
124
Metropolitan Life Insurance Company (MetLife)
New York
$227K
SOADOR
125
State of Alaska Department of Revenue
Alaska
$218K +$1.94K +130 +1%

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.